Infertility around the globe: new thinking on gender, reproductive technologies and global movements in the 21st century
- PMID: 25801630
- DOI: 10.1093/humupd/dmv016
Infertility around the globe: new thinking on gender, reproductive technologies and global movements in the 21st century
Abstract
Background: Infertility is estimated to affect as many as 186 million people worldwide. Although male infertility contributes to more than half of all cases of global childlessness, infertility remains a woman's social burden. Unfortunately, areas of the world with the highest rates of infertility are often those with poor access to assisted reproductive techniques (ARTs). In such settings, women may be abandoned to their childless destinies. However, emerging data suggest that making ART accessible and affordable is an important gender intervention. To that end, this article presents an overview of what we know about global infertility, ART and changing gender relations, posing five key questions: (i) why is infertility an ongoing global reproductive health problem? (ii) What are the gender effects of infertility, and are they changing over time? (iii) What do we know about the globalization of ART to resource-poor settings? (iv) How are new global initiatives attempting to improve access to IVF? (v) Finally, what can be done to overcome infertility, help the infertile and enhance low-cost IVF (LCIVF) activism?
Methods: An exhaustive literature review using MEDLINE, Google Scholar and the keyword search function provided through the Yale University Library (i.e. which scans multiple databases simultaneously) identified 103 peer-reviewed journal articles and 37 monographs, chapters and reports from the years 2000-2014 in the areas of: (i) infertility demography, (ii) ART in low-resource settings, (iii) gender and infertility in low-resource settings and (iv) the rise of LCIVF initiatives. International Federation of Fertility Societies Surveillance reports were particularly helpful in identifying important global trends in IVF clinic distribution between 2002 and 2010. Additionally, a series of articles published by scholars who are tracking global cross-border reproductive care (CBRC) trends, as well as others who are involved in the growing LCIVF movement, were invaluable.
Results: Recent global demographic surveys indicate that infertility remains an ongoing reproductive problem, with six key demographic features. Despite the massive global expansion of ART services over the past decade (2005-2015), ART remains inaccessible in many parts of the world, particularly in sub-Saharan Africa, where IVF clinics are still absent in most countries. For women living in such ART-poor settings, the gender effects of infertility may be devastating. In contrast, in ART-rich regions such as the Middle East, the negative gender effects of infertility are diminishing over time, especially with state subsidization of ART. Furthermore, men are increasingly acknowledging their male infertility and seeking ICSI. Thus, access to ART may ameliorate gender discrimination, especially in the Global South. To that end, a number of clinician-led, LCIVF initiatives are in development to provide affordable ART, particularly in Africa. Without access to LCIVF, many infertile couples must incur catastrophic expenditures to fund their IVF, or engage in CBRC to seek lower-cost IVF elsewhere.
Conclusions: Given the present realities, three future directions for research and intervention are suggested: (i) address the preventable causes of infertility, (ii) provide support and alternatives for the infertile and (iii) encourage new LCIVF initiatives to improve availability, affordability and acceptability of ART around the globe.
Keywords: assisted reproductive techniques; demography; gender; infertility; low-cost IVF.
© The Author 2015. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
Similar articles
-
IVF and other ART in low- and middle-income countries: a systematic landscape analysis.Hum Reprod Update. 2021 Feb 19;27(2):213-228. doi: 10.1093/humupd/dmaa047. Hum Reprod Update. 2021. PMID: 33238297 Free PMC article. Review.
-
Infertility in resource-constrained settings: moving towards amelioration.Reprod Biomed Online. 2013 Feb;26(2):189-95. doi: 10.1016/j.rbmo.2012.11.009. Epub 2012 Nov 29. Reprod Biomed Online. 2013. PMID: 23260034
-
Infertility care and the introduction of new reproductive technologies in poor resource settings.Reprod Biol Endocrinol. 2014 Sep 8;12:87. doi: 10.1186/1477-7827-12-87. Reprod Biol Endocrinol. 2014. PMID: 25201070 Free PMC article. Review.
-
Introducing assisted reproductive technologies in The Gambia, a survey on the perspectives of Gambian healthcare professionals and medical students.BMC Health Serv Res. 2023 Feb 28;23(1):203. doi: 10.1186/s12913-023-09171-7. BMC Health Serv Res. 2023. PMID: 36855053 Free PMC article.
-
Access to assisted reproductive technologies in sub-Saharan Africa: fertility professionals' views.Sex Reprod Health Matters. 2024 Dec;32(1):2355790. doi: 10.1080/26410397.2024.2355790. Epub 2024 Jun 12. Sex Reprod Health Matters. 2024. PMID: 38864373 Free PMC article.
Cited by
-
Mechanisms of Cadmium-Induced Testicular Injury: A Risk to Male Fertility.Cells. 2022 Nov 14;11(22):3601. doi: 10.3390/cells11223601. Cells. 2022. PMID: 36429028 Free PMC article. Review.
-
Access to infertility care in Brazil: validation of a questionnaire for a bioethical discussion.Reprod Health. 2023 Dec 8;20(1):183. doi: 10.1186/s12978-023-01724-7. Reprod Health. 2023. PMID: 38062511 Free PMC article.
-
Analysis of HIF2α polymorphisms in infertile women with polycystic ovary syndrome or unexplained infertility.Front Endocrinol (Lausanne). 2022 Sep 8;13:986567. doi: 10.3389/fendo.2022.986567. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36157441 Free PMC article.
-
Effects of a Chinese Patent Medicine Gushen'antai Pills on Ongoing Pregnancy Rate of Hormone Therapy FET Cycles: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.Front Endocrinol (Lausanne). 2020 Sep 23;11:581719. doi: 10.3389/fendo.2020.581719. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33071986 Free PMC article. Clinical Trial.
-
Unraveling the mysteries of early embryonic arrest: genetic factors and molecular mechanisms.J Assist Reprod Genet. 2024 Dec;41(12):3301-3316. doi: 10.1007/s10815-024-03259-7. Epub 2024 Sep 26. J Assist Reprod Genet. 2024. PMID: 39325344 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous